IBB Core Facilities Educational Seminar
"Multigenic Research: Pursuing New Horizons in Multigenic Therapy Development and Cell Line Engineering" - Featuring BioSolution Designs and OspreyBio
Thomas D. Reed
Founder and CEO, BioSolution Designs
Co-Founder, CSO, OspreyBio
Founder, CSO, Intrexon, now Precigen (1998-2020)
Lunch provided.
This seminar was designed for gene and cell therapy students, researchers, and cell line engineers interested in broadening their understanding of gene therapy development. How can standardized vector building systems accelerate your research and help you to secure grant funding? What are multigenic therapies, and why are they the future of gene and cell therapy research?
In this seminar, we will answer the prior questions and introduce attendees to the many opportunities to expand into this novel area of research.
